The SEC has subpoenaed documents relating to the Latin American operations of Teva Pharmaceutical Industries Ltd. Teva indicated in filings that it has also initiated an internal investigation into “certain business practices which may have Foreign Corrupt Practices Act implications.” The company has hired outside counsel to help with the investigation.

Teva has said that the investigation is still in its early stage. The SEC and DOJ have not commented on the matter.